April 23, 2024
Video
Vikram Narayan, MD, discusses the mechanism of action of nadofaragene firadenovec in patients with high-risk non–muscle invasive bladder cancer.
March 11, 2024
Article
Susan C. Modesitt, MD, FACOG, FACS, sheds light on the latest research with antibody-drug conjugates across gynecologic cancers.
March 08, 2024
Video
Kevin Kalinsky, MD, MS, discusses questions regarding the utility and implementation of genomic testing approaches in hormone receptor–positive breast cancer.
March 04, 2024
Video
Reshma Jagsi, MD, DPhil, discusses the implications of the IDEA trial for patients with breast cancer.
March 01, 2024
Video
Reshma Jagsi, MD, Dphil, discusses caveats when interpreting long-term results from the IDEA trial of radiotherapy omission in breast cancer.
March 01, 2024
Video
Jane L. Meisel, MD, shares information from a study that evaluated patient-reported perceptions of patient-provider communication in breast cancer care.
February 29, 2024
Video
Susan C. Modesitt, MD, FACOG, FACS, discusses the role of PARP inhibitors in the treatment of patients with ovarian cancer.
February 26, 2024
Article
In case you missed it, read a recap of every episode of OncLive On Air recorded in January 2024.
February 22, 2024
Video
Reshma Jagsi, MD, DPhil, discusses 5-year findings from the IDEA trial assessing radiotherapy omission for postmenopausal patients with breast cancer.
February 21, 2024
Video
Jonathon B. Cohen, MD, MS, discusses treatment considerations for mantle cell lymphoma and the role of pirtobrutinib in the management of this disease.
February 21, 2024
Article
The S1706 study is currently enrolling patients with inflammatory breast cancer to determine if adding a PARP inhibitor to radiation therapy is effective.
February 21, 2024
Article
State of the Science Summit - Gynecologic Cancers: Chaired by Susan C. Modesitt, MD, FACOG, FACS
February 20, 2024
Video
Jane L. Meisel, MD, discusses patient-reported perceptions of patient-provider communication in cancer care.
February 19, 2024
Article
Following chemoradiation, maintenance osimertinib improved PFS vs placebo in patients with stage III EGFR-mutant non–small cell lung cancer.
February 16, 2024
Article
Investigating when radiation therapy can be appropriately omitted and striving to uncover disparities are areas of focus in the field of radiation oncology.
February 14, 2024
Video
Jonathon B. Cohen, MD, MS, discusses the background of the BRUIN study of pirtobrutinib in previously treated patients with mantle cell lymphoma.
February 07, 2024
Video
Jane L. Meisel, MD, discusses the rationale for evaluating communication challenges that currently exist between patients and their oncologists.
February 06, 2024
Video
Drs Mayer and Kalinsky conclude their discussion with a look at agents in development and unmet needs for patients with breast cancer and ESR1 mutations.
February 03, 2024
Video
Ticiana Leal, MD, discusses the variety of DLL3-targeted agents in development for patients with small cell lung cancer and neuroendocrine tumors.